Flukiver™
Flukiver™
Flukiver 5% is an oral suspension flukicide containing closantel, for the control of adult and immature liver fluke causing chronic and sub-acute fasciolosis, nasal bots and inhibited, immature and adult stages of Barber Pole worm in sheep and lambs. It can be used in all age groups of sheep and lambs, including during pregnancy, and in rams during the breeding season.
Key Features
- Kills immature & adult liver fluke (Fasciola hepatica) including those resistant to triclabendazole
- Effective against benzimidazole resistant strains of Haemonchus contortus (Barber Pole Worm)
- Can be used in any age sheep or lamb including during pregnancy
Packs available
Flukiver is available in the following pack sizes: 1L ; 2.5L ; 5L
Flukiver Product Information
Target activity
Dosage
Administration
Withdrawal periods
Target activity of Flukiver
Flukiver 5% Oral Suspension controls chronic and subacute liver fluke infections caused by adult and immature Fasciola hepatica in sheep and lambs. It can be used on farms with triclabendazole resistance1.
Flukiver also controls Oestrus ovis (Sheep Nasal Bot Fly) and controls inhibited, immature and adult stages of Haemonchus contortus (Barber Pole Worm) including benzimidazole resistant strains.
Ticks (Ixodes ricinus) feeding on sheep at the time of treatment are likely to produce fewer viable eggs.
Special warnings
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:
- Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
- Underdosing which may be due to underestimation of bodyweight, misadministration of the product or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigation using appropriate tests (eg Faecal Egg Count reduction test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
Resistance to closantel has been reported in Haemonchus species outside the EU. Therefore the use of this product should be used upon local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
Special precautions for use in animals
As overdosage may result in signs of toxicity such as incoordination and blindness, care should be taken to ensure animals are not overdosed by volume. If the product is spilled, care should be taken to ensure animals do not ingest it.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This product may be irritating to skin and eyes and users should be careful not to accidentally splash it on themselves or others. Wear impermeable rubber gloves when applying the product. Remove any contaminated clothing immediately. In case of accidental spillage onto skin or into eyes, rinse the affected area with large amounts of clean water. If irritation persists, seek medical advice immediately and show the package leaflet or label to the physician. This product may be toxic after accidental ingestion. Avoid ingestion by hand-to-mouth contact. Do not eat, drink or smoke whilst handling the product. If accidental ingestion occurs, seek medical attention and show the package leaflet or label to the physician. Wash hands after use.
Other precautions
This product is toxic to aquatic organisms and dung insects. Long-term effects on dung insects caused by continuous or repeated use cannot be excluded. Repeat treatments on a pasture within a season should only be given on the advice of the prescriber. To reduce the risk for dung fauna, if the worming protocol allows, treated and untreated animals should be grazed on the same field. The risk to aquatic ecosystems will be reduced by keeping treated animals away from water bodies for 48 hours after treatment.
